Tetra Radar · FDA Approvals · Decision date
ifezuntirgene inilparvovec: FDA decision date
uniQure N.V. (QURE) · 1 May 2027
The application has been granted Priority Review with a Prescription Drug User Fee Act (“PDUFA”) target action date of May 1, 2027.
Source: 10-Q of 4 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.